FDA Approves CARBIDOPA AND LEVODOPA — Advagen Pharma Ltd

# FDA Approves Generic Carbidopa and Levodopa from Advagen Pharma Advagen Pharma Ltd has received FDA approval for its generic formulation of carbidopa and levodopa, a standard-of-care treatment for Parkinson's disease, which could intensify pricing pressure in the competitive generic neurological market. The approval of ANDA217482 expands the generics landscape for this widely-prescribed combination therapy, potentially benefiting patients through lower-cost alternatives while fragmenting market share among existing manufacturers.